Skip to main content
Signal-Based Action

Real-time oncology signals your team can act on before the window closes

The same signal layer, EMR data, lab results, treatment and progression indicators, can trigger a trial enrollment, a physician outreach, or a care-gap intervention, routed through a human in the loop.

Biomarker, staging and line of therapy signals flow into the patient record, built from EMR and lab data, where an eligible patient is flagged. Inside the decision window, OncoLens AI detects the signal, a person verifies it, and the treating care team is alerted.

How OncoLens helps

Our differentiation lies in our close collaborations with our centers, and our ability to engage HCPs directly

Capture

Biomarker results from every source

  • Not just what shows up in one system
  • OncoLens captures results from in-house labs and NGS vendors alike
  • Results are read as they are generated, inside the clinical workflow
Detect

Indicators that flag exactly when to engage

  • Treatment-based and progression-based indicators
  • They mark the moment a patient approaches a treatment decision
  • They fire even when biomarker testing is not the entry point
Act

Personalized alerts, with a human in the loop

  • OncoLens turns signal into action, once a person has confirmed it
  • A physician outreach
  • A tumor board discussion
  • Targeted HCP education
County-level map showing where patients under care in the OncoLens network are concentrated across the United States, with Alaska and Hawaii shown as insets
Where patients under care are concentrated
225+U.S.-based cancer center locations
6,000,000+patients under care
90%community-based
88%AI-extracted insights

Frequently asked questions

What counts as a “signal” in OncoLens’s signal-based action?

A biomarker result captured from an in-house lab or an NGS vendor, or a treatment- or progression-based indicator drawn from EMR data. Any real-time clinical event that suggests it is time to act, whether that action is research, commercial, or care-team engagement.

How fast can a signal turn into action?

Because signals are captured directly from EMR and lab data as they occur, alerts route through a human-in-the-loop service almost immediately, rather than waiting for claims data or a periodic data refresh to catch up.

Does a human review every alert before it’s acted on?

Yes. Every signal is routed through a human-in-the-loop layer, so a physician outreach, patient pre-screen, or care-gap intervention only happens after a person has confirmed it makes sense.

What kinds of action can a signal trigger?

The same signal layer can support very different next steps depending on the use case: a research team enrolling a patient in a trial, a commercial team engaging a physician, or a care team closing a care gap.

Do signals only come from biomarker testing?

No. Signals include treatment- and progression-based indicators as well as biomarker results, so action can be triggered even when biomarker testing is not the entry point.

Get in touch

Put your signals to work

Share which clinical events matter to your team. OncoLens will show you what it can see, how fast it surfaces, and what happens next.